Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Clustering is widely used to identify subtypes in heterogeneous populations, yet most approaches rarely integrate longitudinal phenotypic trajectories with high-dimensional molecular profiles, limiting their ability to resolve biologically and clinically meaningful heterogeneity in progressive diseases. We developed TPClust, a supervised, semi-parametric clustering method that integrates high-dimensional omics data with longitudinal phenotypes including outcomes and covariates for outcome-guided subtyping. TPClust jointly models latent subtype membership and longitudinal outcome trajectories using multinomial logistic regression informed by molecular features selected via structured regularization, along with spline-based regression to capture subtype-specific, time-varying covariate effects. Simulations demonstrate valid inference for time-varying effects and robust feature selection. Applied to transcriptomic profiles and longitudinal cognitive data from 1,020 older adults in the Religious Orders Study and the Rush Memory and Aging Project, TPClust identified four aging subtypes including intermediate subtypes not captured by unimodal approaches with distinct cognitive trajectories, time-varying risk profiles, clinical and neuropathological features, and multimodal molecular signatures.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12340809PMC
http://dx.doi.org/10.1101/2025.08.05.668514DOI Listing

Publication Analysis

Top Keywords

high-dimensional omics
8
omics data
8
tpclust
4
tpclust temporal
4
temporal profile-guided
4
profile-guided subtyping
4
subtyping high-dimensional
4
data clustering
4
clustering identify
4
identify subtypes
4

Similar Publications

Artificial intelligence (AI) is transforming many fields, including healthcare and medicine. In biomarker discovery, AI algorithms have had a profound impact, thanks to their ability to derive insights from complex high-dimensional datasets and integrate multi-modal datatypes (such as omics, electronic health records, imaging or sensor and wearable data). However, despite the proliferation of AI-powered biomarkers, significant hurdles still remain in translating them to the clinic and driving adoption, including lack of population diversity, difficulties accessing harmonised data, costly and time-consuming clinical studies, evolving AI regulatory frameworks and absence of scalable diagnostic infrastructure.

View Article and Find Full Text PDF

Motivation: The advent of next-generation sequencing-based spatially resolved transcriptomics (SRT) techniques has reshaped genomic studies by enabling high-throughput gene expression profiling while preserving spatial and morphological context. Understanding gene functions and interactions in different spatial domains is crucial, as it can enhance our comprehension of biological mechanisms, such as cancer-immune interactions and cell differentiation in various regions. It is necessary to cluster tissue regions into distinct spatial domains and identify discriminating genes that elucidate the clustering result, referred to as spatial domain-specific discriminating genes (DGs).

View Article and Find Full Text PDF

Single-cell analysis provides critical insights into cellular heterogeneity, dynamic behaviours and microenvironmental interactions, driving advancements in precision medicine and disease mechanism research. However, traditional technologies face limitations due to low throughput, insufficient sensitivity and bottlenecks in multi-omics integration. Microdroplet printing technology, with its advantages in high-throughput single-cell encapsulation, picolitre-level reaction precision and oil-free phase contamination avoidance, has propelled single-cell analysis into a new era of high-throughput and high-dimensional resolution through deep integration with multimodal detection platforms.

View Article and Find Full Text PDF

Sepsis is a complex systemic disease in which systemic toxicity-arising from inflammation-immune dysregulation, oxidative stress, programmed cell death (apoptosis, pyroptosis, ferroptosis), and metabolic reprogramming-drives multi-organ injury. The aim of this review was to synthesize how signaling pathways evolve within and between key organs (lungs, liver, kidneys, heart) and to evaluate whether multi-omics integration and network modeling can identify critical toxic nodes and predict disease progression. We conducted a narrative review of English-language mechanistic studies published between 2015 and 2025 in PubMed, Web of Science, and Scopus, supplemented by bibliography screening, while excluding case reports, conference abstracts, and non-mechanistic work.

View Article and Find Full Text PDF

Artificial intelligence (AI) excels at efficiently processing large volumes of data and extracting valuable insights. Deep Learning (DL), a subfield of AI, utilizes multi-layer neural network algorithms to analyze various types of data, mimicking the neural network architecture of the human brain. One of the most prominent features of DL is its end-to-end learning mechanism, which excels at automatic feature extraction and pattern recognition in data.

View Article and Find Full Text PDF